Skip to content

The effect of Aromatherapy on anxiety

The effect of inhalation of aroma blend containing Lavender, Roman chamomile and Neroli on anxiety and vital signs of Acute Coronary Syndrome patients

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015073023419N1
Enrollment
75
Registered
2016-01-17
Start date
2015-10-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Coronary Syndrom. Acute ischaemic heart disease, unspecified

Interventions

Intervention 1: Intervention droup 1:The aroma group , two drops of the blend of Lavender,Roman chamomile and Neroli oils at a ratio of 6:2:0/5 will be shed on pad eye and the patients are asked fr
Treatment - Other
Placebo
Intervention droup 1:The aroma group , two drops of the blend of Lavender,Roman chamomile and Neroli oils at a ratio of 6:2:0/5 will be shed on pad eye and the patients are asked from a distance of
Intervention group 2: placebo group, patients will be received two drops of distilled water on eyepad and the patiens are asked from a distance of 5cm inhale through 10 deep breaths at 7 pm and th
Control group : will be received conventional nursing care.

Sponsors

Vice Chancellor for research of Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Age between 20-80 years; established diagnosis of Unstable Angina and Miocardial Infarction; not having cardiomyopathy; no indication of cardio pulmonary resuscitation; no history of smelling impairments, allergic, rhinitis, eczema, herbal or essence allergic, respiratory disease such as asthma, anxioligic or mental disorders; close relatives death in recent one month; obtaining a score of more than 20 in the Speilberger State Anxiety Inventory; ability to talk and understand Persian; no need for angiography or surgery in next day after intervention; being oriented to person, place and time Exclusion criteria: Lack of consent ti continue study; experienced cardiac dysrhythmia, pain or dyspnea; death during the study; patients who developed allergy to aroma

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Anxiety. Timepoint: 30 min before intervention and 30 min after intervention and following tomorow morning at 7 am. Method of measurement: Spielberger State-Trait Anxiety.;Blood pressure. Timepoint: 30 min before intervention and 30 min after intervention and each 4 hours until following tomorow morning at 7 am. Method of measurement: manitor Novin 51800 saadat co.;Pulse. Timepoint: 30 min before intervention and 30 min after intervention and each 4 hours until following tomorow morning at 7 am. Method of measurement: Pulse count by the researcher in a minute.;Respiration. Timepoint: 30 min before intervention and 30 min after intervention and following tomorow morning at 7 am. Method of measurement: Visit chest going up and down in a minute by researcher.

Secondary

MeasureTime frame
-. Timepoint: -. Method of measurement: -.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactJale Mohammadaliha

Iran University of Medical Sciences-School of Nursing & Midwifery

mohammadaliha.j@iums.ac.ir+98 21 8888 2885

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026